Connection
Cecilia Low Wang to Risk Factors
This is a "connection" page, showing publications Cecilia Low Wang has written about Risk Factors.
|
|
Connection Strength |
|
|
|
|
|
0.201 |
|
|
|
-
Low Wang CC, Everett BM, Burman KD, Wilson PWF. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs? Circulation. 2019 04 02; 139(14):1741-1743.
Score: 0.065
-
Seggelke SA, Lindsay MC, Hazlett I, Sanagorski R, Eckel RH, Low Wang CC. Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting. Curr Diab Rep. 2017 08; 17(8):64.
Score: 0.058
-
Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016 Jun 14; 133(24):2459-502.
Score: 0.053
-
Wang CC, Reusch JE. Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol. 2012 Nov 06; 110(9 Suppl):58B-68B.
Score: 0.021
-
Gumbiner B, Low CC, Reaven PD. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes. Diabetes Care. 1998 Jan; 21(1):9-15.
Score: 0.004